Structure and biophysics of CBFβ/ RUNX and its translocation products

Tahir H Tahirov, John Bushweller

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

The core binding factor (CBF) transcription factor is somewhat unique in that it is composed of a DNA binding RUNX subunit (RUNX1, 2, or 3) and a non-DNA binding CBFβ subunit, which modulates RUNX protein activity by modulating the auto-inhibition of the RUNX subunits. Since the discovery of this fascinating transcription factor more than 20 years ago, there has been a robust effort to characterize the structure as well as the biochemical properties of CBF. More recently, these efforts have also extended to the fusion proteins that arise from the subunits of CBF in leukemia. This chapter highlights the work of numerous labs which has provided a detailed understanding of the structure and function of this transcription factor and its fusion proteins.

Original languageEnglish (US)
Title of host publicationAdvances in Experimental Medicine and Biology
PublisherSpringer New York LLC
Pages21-31
Number of pages11
DOIs
StatePublished - Jan 1 2017

Publication series

NameAdvances in Experimental Medicine and Biology
Volume962
ISSN (Print)0065-2598
ISSN (Electronic)2214-8019

Fingerprint

Core Binding Factors
Biophysics
Transcription Factors
Fusion reactions
Protein Subunits
Leukemia
Proteins
DNA

Keywords

  • CBFβ
  • NMR
  • RUNX
  • Structure
  • X-ray

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Tahirov, T. H., & Bushweller, J. (2017). Structure and biophysics of CBFβ/ RUNX and its translocation products. In Advances in Experimental Medicine and Biology (pp. 21-31). (Advances in Experimental Medicine and Biology; Vol. 962). Springer New York LLC. https://doi.org/10.1007/978-981-10-3233-2_2

Structure and biophysics of CBFβ/ RUNX and its translocation products. / Tahirov, Tahir H; Bushweller, John.

Advances in Experimental Medicine and Biology. Springer New York LLC, 2017. p. 21-31 (Advances in Experimental Medicine and Biology; Vol. 962).

Research output: Chapter in Book/Report/Conference proceedingChapter

Tahirov, TH & Bushweller, J 2017, Structure and biophysics of CBFβ/ RUNX and its translocation products. in Advances in Experimental Medicine and Biology. Advances in Experimental Medicine and Biology, vol. 962, Springer New York LLC, pp. 21-31. https://doi.org/10.1007/978-981-10-3233-2_2
Tahirov TH, Bushweller J. Structure and biophysics of CBFβ/ RUNX and its translocation products. In Advances in Experimental Medicine and Biology. Springer New York LLC. 2017. p. 21-31. (Advances in Experimental Medicine and Biology). https://doi.org/10.1007/978-981-10-3233-2_2
Tahirov, Tahir H ; Bushweller, John. / Structure and biophysics of CBFβ/ RUNX and its translocation products. Advances in Experimental Medicine and Biology. Springer New York LLC, 2017. pp. 21-31 (Advances in Experimental Medicine and Biology).
@inbook{a7a5449c992a444eb2702a0f0ef000af,
title = "Structure and biophysics of CBFβ/ RUNX and its translocation products",
abstract = "The core binding factor (CBF) transcription factor is somewhat unique in that it is composed of a DNA binding RUNX subunit (RUNX1, 2, or 3) and a non-DNA binding CBFβ subunit, which modulates RUNX protein activity by modulating the auto-inhibition of the RUNX subunits. Since the discovery of this fascinating transcription factor more than 20 years ago, there has been a robust effort to characterize the structure as well as the biochemical properties of CBF. More recently, these efforts have also extended to the fusion proteins that arise from the subunits of CBF in leukemia. This chapter highlights the work of numerous labs which has provided a detailed understanding of the structure and function of this transcription factor and its fusion proteins.",
keywords = "CBFβ, NMR, RUNX, Structure, X-ray",
author = "Tahirov, {Tahir H} and John Bushweller",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-981-10-3233-2_2",
language = "English (US)",
series = "Advances in Experimental Medicine and Biology",
publisher = "Springer New York LLC",
pages = "21--31",
booktitle = "Advances in Experimental Medicine and Biology",

}

TY - CHAP

T1 - Structure and biophysics of CBFβ/ RUNX and its translocation products

AU - Tahirov, Tahir H

AU - Bushweller, John

PY - 2017/1/1

Y1 - 2017/1/1

N2 - The core binding factor (CBF) transcription factor is somewhat unique in that it is composed of a DNA binding RUNX subunit (RUNX1, 2, or 3) and a non-DNA binding CBFβ subunit, which modulates RUNX protein activity by modulating the auto-inhibition of the RUNX subunits. Since the discovery of this fascinating transcription factor more than 20 years ago, there has been a robust effort to characterize the structure as well as the biochemical properties of CBF. More recently, these efforts have also extended to the fusion proteins that arise from the subunits of CBF in leukemia. This chapter highlights the work of numerous labs which has provided a detailed understanding of the structure and function of this transcription factor and its fusion proteins.

AB - The core binding factor (CBF) transcription factor is somewhat unique in that it is composed of a DNA binding RUNX subunit (RUNX1, 2, or 3) and a non-DNA binding CBFβ subunit, which modulates RUNX protein activity by modulating the auto-inhibition of the RUNX subunits. Since the discovery of this fascinating transcription factor more than 20 years ago, there has been a robust effort to characterize the structure as well as the biochemical properties of CBF. More recently, these efforts have also extended to the fusion proteins that arise from the subunits of CBF in leukemia. This chapter highlights the work of numerous labs which has provided a detailed understanding of the structure and function of this transcription factor and its fusion proteins.

KW - CBFβ

KW - NMR

KW - RUNX

KW - Structure

KW - X-ray

UR - http://www.scopus.com/inward/record.url?scp=85015439965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015439965&partnerID=8YFLogxK

U2 - 10.1007/978-981-10-3233-2_2

DO - 10.1007/978-981-10-3233-2_2

M3 - Chapter

C2 - 28299648

AN - SCOPUS:85015439965

T3 - Advances in Experimental Medicine and Biology

SP - 21

EP - 31

BT - Advances in Experimental Medicine and Biology

PB - Springer New York LLC

ER -